Stay updated on Clinical Trial of IL-2 + Nivolumab in RCC

Sign up to get notified when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial of IL-2 + Nivolumab in RCC page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T23:03:54.000Z thumbnail image
  4. Check
    30 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T15:56:24.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T11:16:31.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T02:13:25.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T22:54:42.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:19:05.000Z thumbnail image

Stay in the know with updates to Clinical Trial of IL-2 + Nivolumab in RCC

Enter your email address, and we'll notify you when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.